Pfizer Deutschland GmbH
- Pharmaceutical Sales 2009
-
worldwide: 50.503 billion US-Dollar
in Germany: 2.0 billion EURO
- Product Range
- Cardiovascular diseases, central nervous system disorders, rheumatism and pain, cancer, infectious diseases, inflammatory diseases, allergies, respiratory disorders, metabolic disorders, endocrinology, vaccines, urogenital disorders, gynecological disorders, ophthalmic diseases, dietary supplement, gastro-intestinal and liver diseases
- Key Research Areas
- Alzheimer’s, Inflammation, Oncology, Pain, Psychoses, Diabetes
- R&D Expenditure 2009
-
worldwide: more than 7 billion US-Dollar
in Germany: n/a
- Employees in the Pharmaceuticals Division 2010
-
worldwide: more than 100,000
in Germany: 4,000
(All data based on corporate information, as of: 06/2010)
Unless indicated otherwise, data and keywords refer to the company's human therapeutics sector in Germany and to that of its international Group worldwide.
Unless indicated otherwise, data and keywords refer to the company's human therapeutics sector in Germany and to that of its international Group worldwide.
Suggest page
Print page
Bookmark page